Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients

J Med Virol. 2021 Feb;93(2):582-584. doi: 10.1002/jmv.26406. Epub 2020 Sep 16.

Authors

Wenju Lu¹, Xiaoqing Liu^{1

2}, Tao Wang¹, Fei Liu¹, Airu Zhu¹, Yongping Lin¹, Jieping Luo, Feng Ye¹, Jianxing He¹, Jincun Zhao¹, Yiming Li^{1

2}, Nanshan Zhong²

Affiliations

¹ Division of Respiratory Medicine, State Key Laboratory of Respiratory Diseases, Guangdong Key Laboratory of Vascular Diseases, National Clinical Research Center for Respiratory Diseases, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong, China.
² Department of Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.

No abstract available

Keywords: coronavirus; protein extraction; systemic immunity.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19 / physiopathology*
Cohort Studies
Critical Illness
Female
Humans
Male
Middle Aged
Mucin 5AC / analysis*
Mucin-1 / analysis*
Mucus / chemistry*
Respiratory System

Substances

MUC1 protein, human
MUC5AC protein, human
Mucin 5AC
Mucin-1

Grants and funding